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Mycobacterium tuberculosis is a traditional example of bacteria that uniquely adapted to
evade the host immune system and establish persistent infection. One of the major stres-
ses encountered by M. tuberculosis is the host oxidative immune response. Studies on other
bacteria have suggested that treatment with bactericidal antibiotics may lead to increased
oxidative stress. Moreover, certain studies have shown that oxidative stress may sensitize
bacteria to antibiotics. In addition, increased antioxidant capabilities of bacteria may there-
fore protect them from both antibiotics as well as the host immune response. In multi-drug
resistant (MDR)-M. tuberculosis isolates, the antioxidant capability is weakened by
decreased or even abolished catalase activity. In this presentation, the main focus is direc-
ted to the evidence that host oxidative immune responses could be exploited for better
treatment results of MDR tuberculosis (TB) cases. Some evidences are generated from these
experiences and others are based on others’ experimental studies conducted onM. tubercu-
losis and other bacterial species.
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